Reply to "Serum cytokine profiles predict outcomes of chronic hepatitis B patients discontinuing entecavir or tenofovir therapy"

J Formos Med Assoc. 2024 Feb;123(2):297-298. doi: 10.1016/j.jfma.2023.06.021. Epub 2023 Jul 4.
No abstract available

Publication types

  • Letter

MeSH terms

  • Cytokines
  • Guanine / analogs & derivatives*
  • Guanine / therapeutic use
  • Hepatitis B, Chronic* / drug therapy
  • Humans
  • Tenofovir / therapeutic use

Substances

  • Tenofovir
  • entecavir
  • Guanine
  • Cytokines